Showing results (1081-1090 of 1,138) with videos related to

Sort By:
Pageof 114
Frontiers in Microbiology|June 14, 2021
Respiratory Co-Infections: Modulators of SARS-CoV-2 Patients' Clinical Sub-PhenotypePriyanka Mehta, Shweta Sahni, Samreen Siddiqui, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 2017
Antibody-based assay discriminates Zika virus infection from other flavivirusesAngel Balmaseda, Karin Stettler, Raquel Medialdea-Carrera, et al.
Nature|January 28, 2021
Ebola virus antibody decay-stimulation in a high proportion of survivorsCharlene Adaken, Janet T Scott, Raman Sharma, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 24, 2021
First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in Advanced NSCLC With 1% or Greater Tumor PD-L1 Expression: Patient-Reported Outcomes From CheckMate 227 Part 1Martin Reck, Tudor-Eliade Ciuleanu, Jong-Seok Lee, et al.
The Lancet Regional Health. Europe|August 29, 2022
Epidemiology of SARS-CoV-2 infection among staff and students in a cohort of English primary and secondary schools during 2020-2021James R Hargreaves, Sinéad M Langan, William E Oswald, et al.
Transfusion|March 25, 2018
Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra LeoneRichard S Tedder, Dhan Samuel, Steve Dicks, et al.
Transfusion Medicine (Oxford, England)|December 17, 2020
Convalescent plasma therapy for the treatment of patients with COVID-19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levelsHeli Harvala, Matthew L Robb, Nick Watkins, et al.
Plos One|January 20, 2022
RNA reference materials with defined viral RNA loads of SARS-CoV-2-A useful tool towards a better PCR assay harmonizationLaura Vierbaum, Nathalie Wojtalewicz, Hans-Peter Grunert, et al.
Endocrinology|September 23, 2017
Regulation of Endogenous (Male) Rodent GLP-1 Secretion and Human Islet Insulin Secretion by Antagonism of Somatostatin Receptor 5Thomas B Farb, Marta Adeva, Thomas J Beauchamp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 12, 2022
Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227Julie R Brahmer, Jong-Seok Lee, Tudor-Eliade Ciuleanu, et al.
Pageof 114